tirzepatide weight loss clinical trial results is FDA-approved for management, with trials showing average weight of 15–22.5% over 72 weeks. It's a prescription-only therapy, meaning it's not for everyone, and it works by acting Semaglutide vs Tirzepatide: Which GLP-1

Dehydration compounds headache risk because GLP-1 therapy often reduces appetite for fluids alongside food intake

During this window, focusing on high-protein meals, fiber-rich foods, and consistent physical activity helps preserve muscle mass and metabolic rate, both of which drop when weight loss occurs

cut their weekly food and alcohol spending by an average of 36%, saving up to $6,754 and 4,425 annually

A Measured, Evidence-Informed Approach The Meadows is taking a measured approach to GLP-1 integration: The science is promising, but still early Patient safety guides every decision Screening, monitoring, and interdisciplinary care are essential Medication is always paired with comprehensive treatment As research evolves, our approach will continue to be refined